PubMed · 6992001
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
Tetracycline.. https://pubmed.ncbi.nlm.nih.gov/6992001/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
A new therapeutic approach involves the discovery by the "Stony Brook group," that tetracyclines, but not other antibiotics, can inhibit host-derived collagen-destructive enzymes. This newly discovered property of tetracyclines is unrelated to the antimicrobial activity of these drugs. Examples support the hypothesis that this unexpected property of tetracyclines provides a new approach to treating periodontal diseases as well as a variety of medical disorders.
Explore the source record for details and available documents.
Explore the source record for details and available documents.